"I hope that in 6 months or so from now that we will be the first oral CGRP with the indication for the prevention of migraine," Biohaven CEO Vlad Coric said.
source https://www.cnbc.com/2020/11/18/biohaven-eyes-mid-2021-for-migraine-prevention-drug-launch-.html
0 Comments